Loading…
Novo Nordisk is an industry leader in biopharmaceuticals for type 1 and type 2 diabetes as…
–
Asset Value
1.3%
% of portfolio
-18.5%
Net Return YTD
Performance, year to date.
Novo Nordisk A/S Class B
The chart below shows the share price for the actual year.
Data source: FactSet
Contact our team to arrange for a call.